OncUpdates
  • Conferences
    • ASCO
      • Rapid Reactions
      • Breast Cancer
      • GI Cancer
      • GU Cancer
      • Head and Neck Cancer
      • Hematology
      • Lung Cancer
    • ASCO GI
      • Biliary/Liver Cancer
      • Colorectal Cancer
      • Gastric/GEJ Cancer
      • General GI Cancer
      • Pancreatic Cancer
    • ASCO GU
      • Bladder Cancer
      • General GU Oncology
      • Prostate Cancer
      • RCC
    • ASH
      • General Hematology
      • Leukemia
      • Lymphoma
      • Multiple Myeloma
    • EHA
    • ESMO
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Lung Cancer
    • SABCS
      • General Breast Cancer
      • HER2-Positive Breast Cancer
      • HR+ Disease
      • TNBC
    • WCLC
  • Videos & Podcasts
    • Challenging Cases
      • Breast Cancer
      • GU Oncology
      • Hematology
      • Lung Cancer
    • New Approvals
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Tox Check
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • GI Oncology
      • GU Cancer
      • Head and Neck Cancers
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Clinical Insights
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • GI Oncology
      • Gastric/GEJ Cancer
      • Pancreatic Cancer
    • GU Oncology
      • Bladder Cancer
      • RCC
    • Head & neck cancers
    • Hematology
      • Leukemia
      • MDS
      • Multiple Myeloma
      • Polycythemia Vera
    • Lung Cancer
      • NSCLC
      • SCLC
  • Resource Centers
    • Cell Therapy
    • Metastatic Breast Cancer
    • Pancreatic Cancer
  • Articles
    • Breast Cancer
    • General News
    • GI Oncology
    • GU Oncology
    • Hematology
    • Lung Cancer
  • Events
  • Subscribe
OncUpdates
  • Conferences
    • ASCO
      • Rapid Reactions
      • Breast Cancer
      • GI Cancer
      • GU Cancer
      • Head and Neck Cancer
      • Hematology
      • Lung Cancer
    • ASCO GI
      • Biliary/Liver Cancer
      • Colorectal Cancer
      • Gastric/GEJ Cancer
      • General GI Cancer
      • Pancreatic Cancer
    • ASCO GU
      • Bladder Cancer
      • General GU Oncology
      • Prostate Cancer
      • RCC
    • ASH
      • General Hematology
      • Leukemia
      • Lymphoma
      • Multiple Myeloma
    • EHA
    • ESMO
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Lung Cancer
    • SABCS
      • General Breast Cancer
      • HER2-Positive Breast Cancer
      • HR+ Disease
      • TNBC
    • WCLC
  • Videos & Podcasts
    • Challenging Cases
      • Breast Cancer
      • GU Oncology
      • Hematology
      • Lung Cancer
    • New Approvals
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Tox Check
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • GI Oncology
      • GU Cancer
      • Head and Neck Cancers
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Clinical Insights
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • GI Oncology
      • Gastric/GEJ Cancer
      • Pancreatic Cancer
    • GU Oncology
      • Bladder Cancer
      • RCC
    • Head & neck cancers
    • Hematology
      • Leukemia
      • MDS
      • Multiple Myeloma
      • Polycythemia Vera
    • Lung Cancer
      • NSCLC
      • SCLC
  • Resource Centers
    • Cell Therapy
    • Metastatic Breast Cancer
    • Pancreatic Cancer
  • Articles
    • Breast Cancer
    • General News
    • GI Oncology
    • GU Oncology
    • Hematology
    • Lung Cancer
  • Events
  • Subscribe

RCC

Home / Clinical Insights / GU Oncology / RCC

RCC

Optimizing Sequential Therapy in Advanced RCC with expert team including Dr. David Braun, Dr. Ulka Vaishampayan, Dr. Bradley McGregor, Dr. Rohit Gosain, and Dr. Rahul Gosain for oncology research and treatment advancements.

RCC

12/11/2025

Ep. 5: Optimizing Sequential Therapy in Advanced RCC

Bradley McGregor, MDUlka Vaishampayan, MBBSDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
Second-line RCC management, tolerability, comorbidities, long-term planning expert panel discussion at OncUpdates. Featuring Dr. Bradley McGregor, Dr. David Braun, Dr. Ulka Vaishampayan, Dr. Rohit Gosain, and Dr. Rahul Gosain.

RCC

12/10/2025

Ep. 4: Second-Line RCC Management: Tolerability, Comorbidities, and Long-Term Planning

Ulka Vaishampayan, MBBSBradley McGregor, MDDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates panel discussion on balancing patient goals and efficacy in second-line RCC therapy featuring leading oncologists.

RCC

12/09/2025

Ep. 3: Balancing Patient Goals and Efficacy in Second-Line RCC Therapy

David Braun, MD, PhDUlka Vaishampayan, MBBSBradley McGregor, MDRahul Gosain, MD, MBARohit Gosain, MD
VEGF TKIs in RCC research panel featuring Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. David Braun, and Dr. Bradley McGregor discussing toxicity and tolerability in renal cell carcinoma therapies.

RCC

12/08/2025

Ep. 2: VEGF TKIs in RCC: Toxicity and Tolerability

David Braun, MD, PhDBradley McGregor, MDRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates logo featuring expert healthcare professionals discussing Tivozanib in the current RCC treatment landscape, enhancing oncology and targeted therapy awareness.

RCC

12/07/2025

Ep. 1: Positioning Tivozanib in Today’s RCC Treatment Landscape

Ulka Vaishampayan, MBBSDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD
1. OncUpdates panel discussion on treating advanced renal cell carcinoma (RCC) after first-line therapy with leading oncologists.

RCC

12/06/2025

Treating Advanced RCC After First-Line Therapy (Full Video)

David Braun, MD, PhDBradley McGregor, MDUlka Vaishampayan, MBBSRahul Gosain, MD, MBARohit Gosain, MD

Stay Ahead with the Latest Oncology Insights

Quick links

  • About Us
  • Upcoming Events
  • Contact Us
  • Authors

Legal

  • Terms And Conditions
  • Cookie Policy
  • Privacy Policy
Subscribe To Our Newsletters
  • Subscribe
SignifyMD LLC
PO Box 512, Brielle, NJ 08730

Property of SignifyMD LLC, All Rights Reserved 2026

Oncology Resources | Hematology Support | Community Oncology